367 related articles for article (PubMed ID: 30349037)
1. LAG-3 inhibits the activation of CD4
Maruhashi T; Okazaki IM; Sugiura D; Takahashi S; Maeda TK; Shimizu K; Okazaki T
Nat Immunol; 2018 Dec; 19(12):1415-1426. PubMed ID: 30349037
[TBL] [Abstract][Full Text] [Related]
2. Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity.
Maruhashi T; Sugiura D; Okazaki IM; Shimizu K; Maeda TK; Ikubo J; Yoshikawa H; Maenaka K; Ishimaru N; Kosako H; Takemoto T; Okazaki T
Immunity; 2022 May; 55(5):912-924.e8. PubMed ID: 35413245
[TBL] [Abstract][Full Text] [Related]
3. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.
Huard B; Prigent P; Tournier M; Bruniquel D; Triebel F
Eur J Immunol; 1995 Sep; 25(9):2718-21. PubMed ID: 7589152
[TBL] [Abstract][Full Text] [Related]
4. T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding.
Huard B; Prigent P; Pagès F; Bruniquel D; Triebel F
Eur J Immunol; 1996 May; 26(5):1180-6. PubMed ID: 8647185
[TBL] [Abstract][Full Text] [Related]
5. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.
Demeure CE; Wolfers J; Martin-Garcia N; Gaulard P; Triebel F
Eur J Cancer; 2001 Sep; 37(13):1709-18. PubMed ID: 11527700
[TBL] [Abstract][Full Text] [Related]
6. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
Hannier S; Triebel F
Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.
Johnson DB; Nixon MJ; Wang Y; Wang DY; Castellanos E; Estrada MV; Ericsson-Gonzalez PI; Cote CH; Salgado R; Sanchez V; Dean PT; Opalenik SR; Schreeder DM; Rimm DL; Kim JY; Bordeaux J; Loi S; Horn L; Sanders ME; Ferrell PB; Xu Y; Sosman JA; Davis RS; Balko JM
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568030
[TBL] [Abstract][Full Text] [Related]
8. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects.
Tian X; Zhang A; Qiu C; Wang W; Yang Y; Qiu C; Liu A; Zhu L; Yuan S; Hu H; Wang W; Wei Q; Zhang X; Xu J
J Immunol; 2015 Apr; 194(8):3873-82. PubMed ID: 25780040
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal TCR-CD3 and CD4 Engagement of a Nucleating pMHCII Stabilizes a Functional Receptor Macrocomplex.
Glassman CR; Parrish HL; Lee MS; Kuhns MS
Cell Rep; 2018 Jan; 22(5):1263-1275. PubMed ID: 29386113
[TBL] [Abstract][Full Text] [Related]
10. Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ T cells.
Moon JJ; Dash P; Oguin TH; McClaren JL; Chu HH; Thomas PG; Jenkins MK
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14602-7. PubMed ID: 21873213
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.
Huard B; Tournier M; Hercend T; Triebel F; Faure F
Eur J Immunol; 1994 Dec; 24(12):3216-21. PubMed ID: 7805750
[TBL] [Abstract][Full Text] [Related]
12. Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations.
Chu HH; Moon JJ; Kruse AC; Pepper M; Jenkins MK
J Immunol; 2010 Oct; 185(8):4705-13. PubMed ID: 20861357
[TBL] [Abstract][Full Text] [Related]
13. The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.
Maçon-Lemaître L; Triebel F
Immunology; 2005 Jun; 115(2):170-8. PubMed ID: 15885122
[TBL] [Abstract][Full Text] [Related]
14. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.
Rouhani SJ; Eccles JD; Riccardi P; Peske JD; Tewalt EF; Cohen JN; Liblau R; Mäkinen T; Engelhard VH
Nat Commun; 2015 Apr; 6():6771. PubMed ID: 25857745
[TBL] [Abstract][Full Text] [Related]
15. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.
Wang J; Sanmamed MF; Datar I; Su TT; Ji L; Sun J; Chen L; Chen Y; Zhu G; Yin W; Zheng L; Zhou T; Badri T; Yao S; Zhu S; Boto A; Sznol M; Melero I; Vignali DAA; Schalper K; Chen L
Cell; 2019 Jan; 176(1-2):334-347.e12. PubMed ID: 30580966
[TBL] [Abstract][Full Text] [Related]
17. Bovine Immunoinhibitory Receptors Contribute to Suppression of Mycobacterium avium subsp. paratuberculosis-Specific T-Cell Responses.
Okagawa T; Konnai S; Nishimori A; Ikebuchi R; Mizorogi S; Nagata R; Kawaji S; Tanaka S; Kagawa Y; Murata S; Mori Y; Ohashi K
Infect Immun; 2016 Jan; 84(1):77-89. PubMed ID: 26483406
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.
Huard B; Mastrangeli R; Prigent P; Bruniquel D; Donini S; El-Tayar N; Maigret B; Dréano M; Triebel F
Proc Natl Acad Sci U S A; 1997 May; 94(11):5744-9. PubMed ID: 9159144
[TBL] [Abstract][Full Text] [Related]
19. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.
McKisic MD; Sant AJ; Fitch FW
J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
